NXGLW and NXGL Related Headlines

Go Back

May 19, 2026 09:01AM NEXGEL hydrogel patch reduces laser plume by 95.6% in hair removal study
May 19, 2026 09:00AM NEXGEL Reports Positive Data from Randomized Single-Center IRB Study to Evaluate the Effectiveness and Safety of a Hydrogel Laser Treatment Patch in Laser Hair Removal with a 95.6% Reduction in Plume
May 13, 2026 08:30AM NEXGEL names Dave Hazard VP of sales for BIONX Surgical division
May 13, 2026 08:30AM NEXGEL Appoints Dave Hazard as Vice President of Sales for BIONX Surgical
May 12, 2026 10:27AM NEXGEL To Report First Quarter 2026 Financial Results on May 15th
Apr 27, 2026 09:00AM NEXGEL names Ian Blackman as chief financial officer
Apr 27, 2026 09:00AM NEXGEL Appoints Ian Blackman as Chief Financial Officer
Apr 17, 2026 03:37PM NEXGEL Moves Forward Shareholder Update Call to Discuss Celularity Transaction on April 21st at 4:30 P.M. ET
Mar 31, 2026 04:12PM NEXGEL Reschedules 2025 Financial Results Conference Call to April 8th at 4:30 P.M. ET to Provide Shareholders with an Update on Its Previously Announced Transaction with Celularity

NXGLW and NXGL Related Press Releases

Go Back

May 19, 2026 09:00AM NEXGEL Reports Positive Data from Randomized Single-Center IRB Study to Evaluate the Effectiveness and Safety of a Hydrogel Laser Treatment Patch in Laser Hair Removal with a 95.6% Reduction in Plume
May 13, 2026 08:30AM NEXGEL Appoints Dave Hazard as Vice President of Sales for BIONX Surgical
May 12, 2026 10:27AM NEXGEL To Report First Quarter 2026 Financial Results on May 15th
Apr 27, 2026 09:00AM NEXGEL Appoints Ian Blackman as Chief Financial Officer
Apr 17, 2026 03:37PM NEXGEL Moves Forward Shareholder Update Call to Discuss Celularity Transaction on April 21st at 4:30 P.M. ET
Mar 31, 2026 04:12PM NEXGEL Reschedules 2025 Financial Results Conference Call to April 8th at 4:30 P.M. ET to Provide Shareholders with an Update on Its Previously Announced Transaction with Celularity

NXGLW and NXGL Related SEC Filings

Go Back